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We have cloned cDNAs encoding the rabbit and hu- 
man forms of the Ca2+ release channel of sarcoplasmic 
reticulum. The human cDNA encodes a protein of 5032 
amino acids, with a molecular weight of 563,584, 
which is made without an NHz-terminal signal se- 
quence. Amino acid substitutions between rabbit and 
human sequences were noted in 163 positions and dele- 
tions or insertions in eight regions accounted for ad- 
ditional sequence differences between the two pro- 
teins. Analysis of the sequence indicates that 10 poten- 
tial transmembrane sequences in the COOH-terminal 
fifth of the molecule and two additional, potential 
transmembrane sequences nearer to the center of the 
molecule could contribute to the formation of the Ca2+ 
conducting pore. The remainder of the molecule is 
hydrophilic and presumably constitutes the cyto- 
plasmic domain of the protein. A 114-120 amino acid 
motif is repeated four times in the protein, in residues 
841-954, 955-1068, 2726-2844, and 2845-2958 
and a 16 amino acid part of the motif is repeated twice 
more in residues 1344-1359 and 1371-1386. Al- 
though the channel is modulated by Ca2+, ATP, and 
calmodulin, no clear high affinity Ca’+-binding domain 
of the EF hand type and no clear high affinity ATP- 
binding domain were detected in the primary sequence. 
An acidic sequence in residues 1872-1923 contains 
79% glutamate or aspartate residues and this sequence 
is a potential low affinity Ca2+-binding site. Several 
potential calmodulin-binding sites were observed in 
the sequence, in the region 2800 to 3050. 
Ca*+ release from fractions of the sarcoplasmic reticulum 
containing terminal cisternae has been characterized exten- 
sively during the past decade (Miyamoto and Racker, 1982; 
Morii and Tonomura, 1983; Seiler et al., 1984; Meissner, 1984; 
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Meissner, 1986; Meissner et al., 1986). Rapid Ca2+ release 
from isolated vesicles is activated by micromolar Ca2+ and 
millimolar adenine nucleotides and inhibited by millimolar 
M%+. Calmodulin at micromolar concentrations partially in- 
hibits Ca2+ release, apparently by direct protein-protein in- 
teraction with the Ca’+ release channel. Single channel meas- 
urements in planar bilayers (Smith et al., 1986) have shown 
that Ca2+ release from the sarcoplasmic reticulum is mediated 
by a ligand-gated channel with a conductance greater than 
100 pS in 50 mM Ca’+. 
Identification and isolation of the Ca2+ release channel were 
facilitated through the use of the plant alkaloid, ryanodine 
(Jenden and Fairhurst, 1969), which was shown to bind to 
the protein with high affinity and to modulate its function 
(Seiler et al., 1984; Fleischer et al., 1985; Pessah et al., 1985; 
Pessah et al., 1986; Inui et al., 1987a; Campbell et al., 1987; 
Lai et al., 1987; Lai et al., 1988a). Single channel recordings 
showed that purified ryanodine receptor preparations, com- 
prised of tetrameric complexes of a single major polypeptide 
of M, 350,000-450,000, exhibited an intrinsic Ca2+ channel 
activity that was modulated by Ca’+, ATP, and M%+ (Ima- 
gawa et al., 1987; Hymel et al., 1988; Smith et al., 1988; Lai et 
al., 1988a) in a manner similar to native Ca2+ release channels 
(Smith et al., 1985). Analysis of the stoichiometry and subunit 
composition of the 30 S ryanodine receptor complex indicates 
that it is a cooperatively coupled, negatively charged homo- 
tetramer (Lai et al., 1989). 
Studies of the morphology of the ryanodine receptor (Inui 
et al., 1987a; Lai et al., 1988a; Saito et al., 1988; Wagenknecht 
et al., 1989) have shown it to have an exquisite quatrefoil 
structure, with hydrophobic segments of the four identical 
subunits forming a putative membrane-spanning baseplate 
structure, and hydrophilic segments forming a cytoplasmic 
domain that surrounds and decorates the central baseplate. 
Three-dimensional image reconstruction (Wagenknecht et al., 
1989) suggests the presence of four internal channels which 
branch from a common origin above the baseplate and open 
into vestibules in the four quarters of the tetramer. The 
morphology of the purified Ca2+ release channel shows that it 
makes up the “feet” structures (Franzini-Armstrong, 1970; 
Ferguson et al., 1984) that bridge the gap between the sarco- 
plasmic reticulum and the transverse tubule (Inui et al., 1987a; 
Saito et al., 1988). 
The next major advance in the study of the Ca2+ release 
channel is cloning of the cDNA encoding the protein, thereby 
opening up new avenues of investigation of the protein, in- 
cluding its primary and predicted secondary structure, its 
expression and mutagenesis, and its genomic structure, local- 
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ization, and involvement in disease. Takeshima et al. (1989) 
have reported the cloning and expression of cDNA encoding 
the rabbit skeletal muscle ryanodine receptor and Marks et 
al. (1989) have reported the isolation of partial clones encod- 
ing the rabbit protein. We have reported the cloning of cDNA 
encoding full length rabbit and human skeletal muscle ryano- 
dine receptors and the localization of the ryanodine receptor 
gene to the proximal long arm of human chromosome 19 
(Zorzato et al., 1989a; MacLennan et al., 1989; MacKenzie et 
al., 1989). We have shown that the ryanodine receptor gene 
is not involved in myotonic dystrophy but that it is a candidate 
for the defective gene in malignant hyperthermia. We now 
report the full nucleotide and deduced amino acid sequences 
for the human ryanodine receptor cDNA. These sequences 
will be of great interest as studies of the involvement of the 
ryanodine receptor gene in human muscle disease unfolds. 
EXPERIMENTAL PROCEDURES 
Materials-Hybond nylon membranes, [a-%]dATP [a-“‘PI 
dCTP, and [T-~*P]ATP were from Amersham Corp; Zeta-P;obe blot- 
ting membranes were from Bio-Rad; restriction endonucleases and 
modifying enzymes were from Boehringer Mannheim and Pharmacia 
LKB Biotechnology Inc.; acrylamide and N-N’-bis-acrylamide were 
from Bio-Rad; low melting point agarose was from FMC Bio Products; 
electrophoresis grade agarose was from Schwartz Biotechnology; al- 
kaline phosphatase-conjugated anti-guinea pig IgG and the Riboclone 
EcoRI adaptor system were from Promega; nitrocellulose filters were 
from Millipore; oligo(dT)-cellulose and dextran sulfate were from 
Pharmacia LKB Biotechnology Inc.; the Bluescript vector, the 
EroIII/mung bean nuclease deletion kit, the XZAP II cloning vector, 
and the Gigapack Gold packaging extracts were from Stratagene; 
nucleic acid sequencing kits were from Pharmacia LKB Biotechnol- 
ogy Inc. and United State Chemical Corporation; oligonucleotides 
were from Allelix. 
RNA and DNA Manipulations-mRNA from neonatal rabbit skel- 
etal muscle and adult human muscle (kindly provided by Dr. R. G. 
Worton. Hosuital for Sick Children. Toronto) was isolated as de- 
scribed by MacLennan and de Leon (1983). For Northern blotting, 
poly(A)+ RNA from neonatal rabbit skeletal muscle was separated in 
formaldehyde-agarose gels and transferred to Hybond nylon mem- 
branes. Hybridization to restriction endonuclease fragments of cDNA 
or genomic DNA was carried out as described by Wahl et al. (1979). 
A human dystrophin cDNA probe (Ray et al., 1585) used in Northern 
blot analysis was a kind gift from Drs. H. Klamut and R. G. Worton, 
Toronto. Other manipulations of mRNA and DNA were carried out 
using standard protocols (Maniatis et al., 1982) with the exception of 
DNA transfers to nitrocellulose. In this case, DNA was transferred 
electrophoretically to Zeta-Probe nylon membranes for 60 min at 50 
V using the transfer apparatus described by Gershoni et al. (1980), in 
a buffer consisting of 45 mM boric acid, 45 mM Tris, and 1 mM 
EDTA, pH 8.0. Labeling of cDNA probes was carried out with [a- 
“2PlATP using the olieolabeline kit suonlied bv Pharmacia LKB 
Biotechnology-Inc. Sequencing gf cDNAwas carried out using the 
dideoxy method of Sanger et al. (1977). Templates for sequencing 
were prepared in the Bluescript vector using the ExoIII/mung bean 
nuclease deletion strategy. 
Isolation of Rabbit cDNA Clones-The Xgtll cDNA expression 
library, constructed from poly(A)’ RNA from rabbit fast-twitchpsoas 
muscle (Ellis et al., 1988) was a gift from Drs. S. B. Ellis and M. 
Harpold, Salk Institute, Biochemistry/Industrial Associates, San 
Diego, CA and Dr. A. Schwartz, Department of Pharmacology, Uni- 
versitv of Cincinnati. Cincinnati. OH. The librarv was screened with 
an affinity purified polyclonal antibody (Zorzato et al., 198913) specific 
for the Ca2+ release channel. Screening of the library was carried out 
by the method of Young and Davis (1983), essentially as described 
by Leberer et al. (1989a). 
The screening of 3 X lo6 recombinants led to the isolation of two 
cDNA clones in the region defined by nucleotides 14280-14629 and 
13434413758 in Fig. 1. Analysis of the sequences of these clones 
showed that both were rearranged when compared with the linear 
sequence of the human cDNA, which was by then available in our 
laboratory. Accordingly, restriction endonuclease fragments from 
these isolated cDNA clones were used as probes to isolate longer, 
unrearranged cDNA clones from the neonatal rabbit skeletal muscle 
cDNA library described by MacLennan et al. (1985). The longest 
clone that we obtained was 6.8 kb’ and it is defined by nucleotides 
8615-15241 in Fig. 1. This clone was subcloned into the Bluescript 
vector and sequenced. 
The clone was extended by construction of a primer extension 
library using 100 pg of neonatal rabbit muscle poly(A)+ RNA. The 
primer site was defined with 0.25 nmol of an 18.mer oligonucleotide 
complementary to the rabbit equivalent of residues 9118-9135 in Fig. 
1 (residues 9123-9140 in Takeshima et al. (1989)). Primer extension 
was carried out using a cDNA synthesis kit provided by Bethesda 
Research Laboratories. After second-strand synthesis, cDNAs were 
blunt ended by adding 2 units of T4 DNA polymerase/ug of DNA to 
the reaction mixture. The cDNA was phenol-chloroform extracted, 
ethanol precipitated, and then size fractionated by separation on 
0.5% low melting point agarose gels in 90 mM Tris, 90 mM boric acid, 
1 mM EDTA buffer, pH 8.0. A 20.fold molar excess of EcoRI adaptors 
were added to the size-fractionated cDNA, and the sample was ligated 
for 4 h at 20 “C with 2 units of T4 DNA ligase. The sample was then 
phosphorylated with 10 units of T4 polynucleotide kinase. Excess 
adaptor was removed by spin-column chromatography and aliquots 
containing an equimolar ratio of DNA to vector arms were ligated 
overnight at 15 “C, in 5 ~1, to 1 pg of dephosphorylated arms of the 
XZAPII vector using 2 units of T4 DNA ligase. In vitro packaging 
was performed with l-2.~1 aliquots of each ligation mixture using the 
Gigapack Gold packaging extract. Subsequent screening was carried 
out with the unamplified library. In the first primer extension, the 
cDNA was extended up to nucleotide 4527. In the second extension, 
an 18mer oligonucleotide complementary to the rabbit equivalent of 
residues 4892-4909 in Fig. 1 (residues 4900-4917 in Takeshima et al. 
(1989)) was used to extend the cDNA to nucleotide 3231. In the third 
and final primer extension, an 18 mer oligonucleotide complementary 
to the rabbit equivalent of residues 3499-3516 in Fig. 1 (residues 
3502-3519 in Takeshima et al. (1989)) was used to extend the se- 
quence into the 5’-untranslated region of the mRNA. 
Isolation of Human cDNA Clones-Rabbit ryanodine receptor 
cDNA probes were used to screen a human fetal psous muscle cDNA 
library in XgtlO (Koenig et al., 1987), kindly provided to us by Drs. 
M. Koenig and L. M. Kunkel, Harvard University, Boston, MA. 
Cross-hybridization was strong for all of the clones isolated, and 
washing was carried out with relatively high stringency (0.1 x SSCP 
at 62 “C, Maniatis et al., 1982). In the first screen, over 30 clones 
were isolated but only one, of about 2000 bp (clone 2 in Fig. l), had 
an internal EcoRI restriction site. All others terminated at an EcoRI 
restriction site 1641 bp upstream of the poly(A) site (Fig. l), suggest- 
ing that the cDNA used to make the library was undermethylated, 
allowing the full length cDNA to be cleaved at EcoRI sites prior to 
its ligation into the XgtlO vector. Accordingly, it was necessary to 
isolate rabbit cDNA clones first and then to use them as probes to 
identify and isolate new human cDNA clones. Eventually, a series of 
six linear cDNA clones were isolated from the library using rabbit 
cDNA probes (Fig. 1). As a further complication in the isolation of 
human cDNA clones, an adenine-rich region between residues 8501 
and 8512 in Fig. 1 acted as a second priming site for cDNA synthesis. 
While this led to the synthesis of an enhanced number of clones 
upstream of this site, it also terminated transcription. Thus clones 4 
and 5 in Fig. 1 were separated, not by an EcoRI cleavage site, but by 
an actual gap in the cDNA. Clone 6 was the last cDNA clone isolated 
from the library and it represented the 5’ end of cDNAs primed at 
the internal poly(A) site. The final clone, clone 7, was obtained from 
a primer extension library constructed from human skeletal mRNA 
using the protocols that were used for primer extension of rabbit 
skeletal muscle mRNA. In this case the primer was a 17-mer oligo- 
nucleotide complementary to residue 2620-2636 in Fig. 1. 
Genomic DNA encoding sequences overlapping the various EcoRI 
restriction sites and the gap in the cDNA introduced by the second 
primer initiating site were isolated from a chromosome 19-specific 
library constructed by Dr. Pieter de Jong, Lawrence Livermore Na- 
tional Laboratories, Livermore, CA, and provided to us under the 
designation Lawrence Livermore LLlSNLOl Human Chromosome 
19 library in Charon 40 by the American Type Culture Collection, 
Rockville, MD. 
Purification of Tryptic Peptides and Sequence Analysis-The Ca2+ 
release channel complex of rabbit skeletal muscle was isolated from 
heavy sarcoplasmic reticulum membranes enriched in [3H]ryanodine 
i The abbreviations used are: kb, kilobase; bp, basepair; CHAPS, 
3-[(3-cholamidopropyl)dimethylammonio]-propanesulfonic acid; 
H-PLC, high performance liquid chromatography. 
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FIG. 1. Characterization of cDNA encoding the human ryanodine receptor. A, restriction endonuclease 
mapping and sequencing strategy. The first line shows the size in kb of the full length cDNA. The second shows a 
partial restriction endonuclease map of the 15.3-kb cDNA which encodes the human ryanodine receptor. The third 
and fourth lines define the six cDNA clones (I-6) that were isolated from the full cDNA library and the single 
clone (7) that was isolated from a primer-extended human cDNA library. Arrows inside the clones indicate that 
they were all sequenced in two directions. The fifth line designates the regions where genomic DNAs were 
sequenced to obtain overlapping sequences between the various clones. B, nucleotide and deduced amino acid 
sequence of the cDNA encoding the human ryanodine receptor. The nucleotides are numbered positively beginning 
at the first residue of the initiator methionine codon. The nucleotides comprising the 5’-non-translated region are 
numbered negatively in the 3’ to 5’ orientation. The deduced amino acid sequence of the open reading frame is 
numbered from 1 to 5032. Peptide sequences determined from the purified receptor are underlined once. The 
potential phosphorylation sites are underlined twice. 







































































































































































































































binding and 45Ca2’ release activity by solubilization in CHAPS, 
followed by density gradient centrifugation through 5-20% sucrose 
in a Beckman SW 28 rotor as described previously (Lai et al., 1988). 
The t3H]ryanodine receptor peak, which sedimented with an apparent 
sedimentation coefficient of 30 S, was collected, concentrated in a 
Centriprep C-30 concentrator (Amicon), and recentrifuged as de- 
scribed above. Sodium dodecyl sulfate polyacrylamide gel analysis of 
the pooled [3H]ryanodine receptor peak on a linear 5-12% polyacryl- 
amide gradient gel revealed a single major high molecular weight 
band with an apparent relative molecular mass of a 400,000 (Lai et 
al., 1988a). 
Hydrophilic tryptic peptides from the purified ryanodine receptor 
(2 mg) were obtained by the procedure of Rao et al., (1988), separated 
by reverse-phase-HPLC on a Vydac Cl* column, and subjected to 
automated NHP-terminal analysis by Edman degradation in an Ap- 
plied Biosystems 470 gas-phase sequenator with an on-line HPLC 
system for phenylthiohydantoin derivative analysis. Peptides 1742- 
1748 and 3196-3210 in Fig. 1 were obtained in this way. Two attempts 
to obtain the NHZ-terminal sequence of the native (unproteolysed) 
ryanodine receptor following dialysis against 0.05% sodium dodecyl 
sulfate were unsuccessful. In an alternative approach, the ryanodine 
receptor was isolated from trypsin-treated heavy sarcoplasmic retic- 
ulum membranes (Meissner et al., 1989) using the sedimentation 
procedure described above. The concentrated ryanodine receptor 
fractions were run on preparative 5-15% linear polyacrylamide gra- 
dient gels (60 rg/lane), then transferred electrophoretically with 80% 
efficiency to PVDF membranes (Immobilon, Millipore) at 8 “C and 
500 mA for 12 h (Moos et al., 1988; Otter et al., 1987). Membranes 
were treated with 0.1% Coomassie Brilliant Blue R-250, and discrete, 
well-stained protein bands were excised and sequenced in a gas-phase 
sequenator as described above. Peptides 1629-1632 and 3119-3130 in 
Fig. 1 were obtained in this way. 
Structural Analysis-Secondary structure was predicted by the 
methods of Garnier et al. (1978) and Chou and Fasman (1974). A 
search for Ca*+-binding sites of the EF hand class was made using 
the template method of Taylor (1986). The scoring of the critical 
sites was adjusted so that when the program was run against the 
whole data base, it gave scores of about 100,000 to all known authentic 
members of the family. Any score less than about 3,000 was considered 
to be insignificant. Potential calmodulin-binding sites were identified 
as predicted a-helices containing clusters of 2-4 positive charges, 
separated by a predominantly hydrophobic region, which are the 
usual requirements for a calmodulin-binding site (Buschmeier et al., 
1987; Harris et al., 1988; Lear et al., 1988). There is no sequence 
generally diagnostic of a nucleotide-binding site, although many 
contain a glycine-rich loop GXGXXG(KT) following the first p- 
strand of a P-a-@ alternation (Wierenga and Hol, 1983). Glycine-rich 
loops are found in many other situations and, since 90% of known 
nucleotide sites belong to a family of parallel p sheets, many irrelevant 
candidates were eliminated by restricting the search to predicted @- 
ol-/3 regions. Potential transmembrane segments were identified by 
the methods of Kyte and Doolittle (1982) and Engelman et al. (1986) 
as implemented in the University of Wisconsin Genetics Computer 
Group program package for DNA and protein sequence analysis. 
RESULTS 
cDNA Isolation-In our initial screening of the Xgtll li- 
brary, we isolated clones whose expressed product reacted 
with an antibody specific for the Ca*+ release channel protein 
(Zorzato et al., 1989b). The fusion protein expressed by these 
isolated clones also reacted with a second antibody raised 
against the purified 30 S ryanodine receptor (Meissner et al., 
1989). As supporting evidence that we had isolated the correct 
clones, both rabbit and human probes from the coding region 
of the DNA hybridized to a message of about 15 kb in rabbit 
muscle mRNA (Fig. 2, A and B). These observations provided 
evidence that we had cloned cDNA encoding the ryanodine 
receptor. As we extended these cDNAs and analyzed their 
sequences, we found four deduced amino acid sequences that 
corresponded to the sequences of peptides isolated from the 
purified ryanodine receptor. These sequences are underlined 
in Fig. 1B. As further supporting evidence that the clones 
encoded the ryanodine receptor, we noted that the deduced 
amino acid sequence would give rise to a protein with several 
transmembrane passages at the carboxyl-terminal end and 
that the bulk of the protein was hydrophilic. Such a protein 
would match very well with the structure of the ryanodine 
receptor in which the bulk of the protein is cytoplasmic and 
only a small segment is transmembrane (Wagenknecht et al., 
1989). The simultaneous sequencing of both rabbit and human 
cDNAs gave us confidence that cloning artifacts did not arise 
in these very long sequences. 
cDNA Sequence-In Fig. lA we present the restriction map 
and sequencing strategy for the human ryanodine receptor 
cDNA. In Fig. lB, we present the nucleotide and deduced 
amino acid sequences. The sequence was determined from 
linear clones 1,3,4,5,6, and 7 in Fig. L4, which abutted each 
other at EcoRI sites between clones 1 and 3, 3 and 4, and 5 
and 6. The junction between clones 1 and 3 was sequenced in 
clone 2, which contained an intact EcoRI restriction site, and 





FIG. 2. Northern blot analysis of RNA from neonatal rabbit 
skeletal muscle. Poly(A)’ RNA from neonatal rabbit tissues skeletal 
muscle was separated in formaldehyde-agarose gels and transferred 
to Hybond nylon membranes. Ribosomal RNA bands corresponding 
to 4.7 and 1.9 kb are indicated. A, hybridization of neonatal rabbit 
skeletal muscle mRNA to a human ryanodine receptor genomic DNA 
fragment covering the cDNA clone g-clone 7 boundary, as indicated 
in Fig. 1. The arrowhead indicates the size of the dystrophin transcript 
(14 kb, Koenig et al., 1987) which was analyzed in the same blot. B, 
hybridization of neonatal rabbit skeletal muscle mRNA to a rabbit 
ryanodine receptor cDNA probe (residues 8612-9215). 
junctions between clones 3 and 4, 4 and 5 (a gap was intro- 
duced in this segment of cDNA by a second oligo(dT) primer 
initiation site), and 5 and 6 were obtained through sequencing 
of genomic DNA clones isolated from the human chromosome 
19 library. The region around the EcoRI site in clones 6 and 
7 was also sequenced in genomic DNA. 
The 3’-untranslated region, beginning after the TGA ter- 
mination codon, was 142 bp long. A canonical AAAATAAA 
polyadenylation signal (Proudfoot and Brownlee, 1976) was 
found 19 bases upstream of the polyadenylation site and this 
was followed closely by the TG-rich sequence TCTGTCGT- 
ACG, characteristic of sequences between the polyadenylation 
signal and the polyadenylation site (McLauchlan et al., 1985). 
The initiator methionine was found 15,096 bp upstream of 
the termination codon. The initiator methionine codon was 
present in the longer sequence ACATCATGG which closely 
resembles the consensus initiation sequence, CCA(G)CCA- 
TGG (Kozak, 1984). Although the 105 bp upstream of the 
initiator methionine were in frame, the sequence contained 
about 75% G+C residues, characteristic of 5’-untranslated 
sequences in other sarcoplasmic reticulum protein cDNAs 
(MacLennan et al., 1985; Brand1 et al., 1986). We were unable 
to obtain an NH*-terminal amino acid sequence from the 
ryanodine receptor protein, which would have been helpful in 
defining the position of the initiator methionine in the cDNA 
sequence, and we conclude that the NHz-terminal methionine 
is blocked in the mature protein. The study of Takeshima et 
al. (1989), in which the cap site for the rabbit mRNA was 
found to lie 138 residues upstream of the initiator methionine 
codon, is our final guide to the placement of the initiator 
methionine in Fig. 1. 
Amino Acid Sequence Analysis-Our human cDNA se- 
quence encoded a protein of 5,032 amino acids with a molec- 
ular weight of 563,584. This deduced molecular mass is con- 
siderably larger than that previously predicted for the ryano- 
dine receptor, on the basis of its mobility in sodium dodecyl 
sulfate gels. It is, however, consistent with the large mass of 
the foot protein (Saito et al., 1988) and with measurements of 
ryanodine binding to the purified tetrameric protein (Lai et 
al., 1988). 
In Fig. 3, third lane, we present the deduced amino acid 
sequence of the human ryanodine receptor in a single-letter 
code. In the second line (above the linear sequence), we have 
indicated positions where we found differences with the rabbit 
sequence. In the first line (two above the linear sequence) we 
have noted discrepancies between our rabbit cDNA sequence 
and that presented by Takeshima et al. (1989). Two discrep- 
ancies are recorded. We did not find the sequence -Ala-Gly- 
Asp-Ala-Gln-, recorded by Takeshima et al. (1989) as residues 
3481-3485, in either our rabbit or human cDNA sequences. 
Residue 2015 was recorded as Glu by Takeshima et al. (1989), 
but we find Asp at this position in rabbit and Gly at this 
position in the human sequence. 
Amino acid differences between the rabbit and human 
sequences are scattered throughout the molecule and involve 
several deletions and/or additions. This is pronounced in the 
Glu-rich region lying between residues 1872 and 1923. In this 
region of the rabbit sequence, a single stretch of 18 Glu is 
found and the whole region has 39 Glu and 4 Asp residues. In 
the comparable human sequence there are 35 Glu and 4 Asp 
residues. A deletion of 3 Glu in a row and then 1 Glu in the 
human sequence are later compensated for by the inclusion 
of the sequence Thr-Ala-Gln and later still by the inclusion 
of a Gly so that, over the course of about 40 residues, the 
sequences realign. Overall, we noted 163-amino acid substi- 
tutions between the two proteins, while deletions or insertions 
in eight different positions accounted for many more differ- 
ences between the two proteins. 
Trunsmembrune Sequence Predictions-The hydropathy of 
the deduced amino acid sequence of the human ryanodine 
receptor is presented in Fig. 4. We identified 11 sequences 
which were long enough to span the membrane, gave mean 
hydropathy indices for a window of I7 amino acids ranging 
from 1.2 to 2.9, and are candidates for transmembrane se- 
quences located in the baseplate of the protein. A 12th poten- 
tial transmembrane sequence (sequence 9) is also included in 
Figs. 3 and 5. Although its hydropathy index is only 0.8, 
largely because of a cluster of 4 glycine residues which do not 
score highly in hydropathy plots but are compatible with a 
hydrophobic environment, this sequence resembles the other 
putative transmembrane sequences in other respects. M’ and 
M” are isolated in the central region of the molecule in 
residues 3123-3134 and 3187-3205, while sequences Ml to 
Ml0 are distributed in the COOH-terminal fifth of the mol- 
ecule between residues 3978 and 4932. In the amino acid 
sequences of these potential transmembrane sequences listed 
in Fig. 5, the charged and amide-containing residues are boxed. 
These sequences could form six pairs of transmembrane pas- 
sages with loops in the lumen of the sarcoplasmic reticulum, 
44, 18, 40, 67, 16, and 19 amino acids in length, progressing 
from NH, to COOH termini. 
Homology Searches-A search of the EMBL/GenBank data 
base has revealed relatively little sequence identity between 
the ryanodine receptor and any other protein. The most 
conspicuous identities were with sequences from the predicted 
transmembrane regions of the ryanodine receptor and the 
Na’ (Noda et al., 1984) and Ca2+ (Tanabe et al., 1987) channels 
and the acetylcholine receptor (Noda et al., 1983) (Fig. 3). 
Repeated Segments-We observed a repeating sequence 
motif of 114-120 amino acids, averaging 28% identity, and 
occurring four times in two doublets. The first and second 
repeats are 114 residues long and include residues 841-954 
and 955-1068. The third and fourth repeats are 120 residues 
long and include residues 2725-2844 and 2845-2958. In order 
to make the appropriate alignment, a B-residue gap was intro- 
duced into repeat sequence 4 between residues 2899 and 2900. 
A 16-residue segment of the longer motif is repeated twice 
more in residues 1344-1359 and 1371-1386. 
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FIG. 3. Secondary structure and domains of the human and rabbit ryanodine receptor amino acid 
sequences. The first line provides information on sequences below; (i), the numbering for the human ryanodine 
receptors sequence at intervals of about 100 amino acids; (ii), a commentary on predicted domain structure over 
long sequences; (iii), locations where our rabbit cDNA sequence differed from the cDNA sequence determined by 
Takeshima et al. (1989); (iv) location of repeated sequences; (v), location of potential calmodulin binding sites. 
The second line indicates the rabbit amino acid sequence only where it differs from the human sequence. The third 
line gives the human amino acid sequence in full. The fourth line provides the predicted secondary structure ((Y 
helix = = =, or /3 strand ---) and hydrophobic segments M’, M”, and MI-M,, for the full sequence in the third 
line. In the last three grouping of lines, matches to the Na’ channel (second repeat) and to the nicotinic acetylcholine 
receptor (M, and MS) are shown. The matches to the former are shown above the sequence on the secondary 
structure line; those to the latter are below the sequence. 
The repeated segments are aligned in Fig. 6. The sequence p-al pattern, with the possibility of a third p-a unit if the final 
identity is not high, but it is sufficient to imply a common helix is extended and interrupted by a short @ strand. TWO 
tertiary structure (Chothia and Lesk, 1986). Although the units in tandem would be predicted to give a viable parallel B 
predicted secondary structure (Fig. 3) for the four repeats sheet domain. 
differ in some segments, the consensus (Fig. 6) shows a ,&I- The “profile” method of Gribskov et al. (1987) was used to 
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FIG. 4. Hydropathy profile of the human ryanodine recep- 
tor. The hydropathy plot (Kyte and Doolittle, 1982) was plotted 
using a window of 17 amino acids. The vertical lines indicate the 
hydropathy index; the horizonoral line indicates the amino acid resi- 
due numbers. 
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FIG. 5. Potential transmembrane sequences in the human 
ryanodine receptor. The sequences of 12 hydrophobic sequences 
near the COOH terminus of the human ryanodine receptor are 
compared. Charged and amide-containing residues are circled. Mean 
hydropathy indices with a window of 17 residues for sequences M’, 
M”, and MI-MI0 are 1.3, 1.5, 1.6, 1.6, 1.2, 1.4, 2.4, 2.0, 1.2, 2.3, 0.8, 
and 2.9, respectively. 
scan the NBRF data base to see if any similar segments 
occurred elsewhere. The highest score of 37 (0.34 of the 
maximum score) was given by a segment of vinculin, but the 
resemblance was not significant. 
Ligand Rinding Sites-The Ca*+ release channel is modu- 
lated by four physiologically relevant molecules; Ca’+, MC, 
ATP, and calmodulin (Meissner, 1986; Meissner et al., 1986; 
Morii and Tonomura, 1983). Therefore, it is of interest to 
determine where in the sequence these ligands bind, especially 
since consensus high affinity binding sequences are available 
for three of them. 
Ca2+ is bound with high affinity to EF hand structures in 
many proteins (Kretsinger, 1987). No sequence with the pre- 
cise characteristics of an EF hand is present in either the 
human or rabbit ryanodine receptors, although several se- 
quences meet the requirements in part. The maximum score 
obtained for all potential sequences was 750, well below the 
score that we consider to be significant. The glutamate-rich 
region between residues 1872 and 1923 is of interest as a 
potential low affinity Ca2+-binding domain, in light of the 
capacity of such sequences to bind Ca2+ with low affinity 
(Fliegel et al., 1987; Leberer et al., 1989b). Magnesium-binding 
sites have not yet been defined and cannot be predicted in 
the primary structures of proteins. 
We were also unable to detect a convincing consensus 
sequence for adenine nucleotide binding in the primary se- 
quences of the rabbit and human receptors. GXGXXG motifs 
were found at positions 1194-1199 and 4447-4452 in Fig. 1. 
The first lies in a region that is predicted to contain several 
@ strands. The second occurs in a glycine-proline-rich region 
where proline bends might give a rather rigid structure, unlike 
that of a typical nucleotide-binding site. 
Potential calmodulin-binding sites made up from an am- 
phipathic helix, with two clusters of positive charges separated 
by a hydrophobic region, were found between residues 2807 
and 2840,2909 and 2930, and 3031 and 3049. These sites are 
indicated in Fig. 3. One of these (2909-2930) showed some 
sequence homology to the calmodulin-binding site of /3 spec- 
trin (Harris et al., 1988). 
The sites of CAMP and calmodulin-dependent protein ki- 
nase phosphorylation have been well characterized (Feram- 
isco et al., 1980). Potential phosphorylation sites were found 
in the protein at residues 3940-3945 and 4314-4317. Glyco- 
sylation sites are composed of the sequence N-X-T(S). We 
found N-X-T(S) sequences which would be glycosylated at 
positions 1064, 2773, 3127, 3943, 4142, and 4859 in the se- 
quence, provided they were luminally located. 
DISCUSSION 
In this paper we have described the cloning and sequence 
analysis of cDNAs encoding one of the largest proteins ana- 
lyzed to date, the rabbit and human forms of the ryanodine 
receptor. The rabbit and human sequences were found to be 
very similar. Major differences were found in an extremely 
acidic region of the protein (residues 1872-1923 in Fig. 1) in 
which several deletions and insertions were noted between 
the two sequences. We found several long amino acid se- 
quences (residues 2948-3293, 3764-4096, 4534-5032) which 
exhibited complete identity with the corresponding rabbit 
sequence. The first conserved region contains putative cal- 
modulin binding sequences, whereas the last two sequences 
contain putative transmembrane sequences Mi and Mz and 
Ms to MiO. In other regions, the differences were minor and 
fully consistent with species differences in the same gene, as 
opposed to differences between different genes. We noted only 
one significant difference between our rabbit cDNA sequence 
and that published by Takeshima et al. (1989). A stretch of 
five amino acids reported in their sequence was absent from 
ours. We cannot readily explain this discrepancy as an allelic 
variation. It may represent an alternative splicing of a small 
exon or the retention of an unexcised intron in the Takeshima 
sequence. This sequence would not appear to be essential to 
function, since the rabbits used in both studies were consid- 
ered normal. The region is predicted to form a turn (Fig. 3), 
so its loss or inclusion would not be likely to disrupt a helix 
or strand domain. The Asp for Glu replacement that we found 
at position 2015 is conservative and could represent an allelic 
variant. 
A major goal in obtaining the primary sequence of a mem- 
brane protein is to deduce features relating to the structure 
and function of the protein. Hydropathy plots (Fig. 4) illus- 
trate that, with the exception of the sequences labeled M’ and 
M” in Fig. 3 (residues 3123-3143 and 3187-3205), the first 
4000 amino acids are hydrophilic and are likely to constitute 
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the cytoplasmic domain of the ryanodine receptor. The cle- 
arest boundaries in this portion of the molecule are provided 
by the four 114 or 120 residue repeats (Fig. 6), occurring in 
two tandem pairs, and three regions rich in runs of glutamic 
acid residues (1870-1930, 2025-2090, and 3675-3750). In be- 
tween these fairly well-defined segments are regions, typical 
of globular proteins, in which predicted a-turn-a, p-turn-p, or 
p-turn-a-turn-p supersecondary motifs predominate. Some of 
these are indicated in Fig. 3. 
We have identified two potential transmembrane sequences 
near the middle of the molecule and 10 in the COOH-terminal 
fifth of the molecule which are candidate sequences for the 
transmembrane channel of the baseplate. The size of the 
baseplate, made up from transmembrane sequences of tour 
subunits (Wagenknecht et al. (1989), is about 140 X 140 A. A 
structure of this size Fould accommodate up to 150 transmem- 
brane helices of 11 A diameter (Engelman et al., 1980), pro- 
vided it were free of lipid or of polar segments of the protein 
embedded in the hydrophobic helices, while each monomeric 
subunit could accommodate about 36 transmembrane se- 
quences. If sequences M’, M”, and Ml-Ml0 were all trans- 
membrane, then six transmembrane hairpin loops, one near 
the center of the molecule and five in the COOH-terminal 
fifth of the molecule would anchor each monomer to the 
membrane and the total number of transmembrane sequences 
in the tetramer would be 48. 
Of the 12 sequences proposed to be transmembrane, four, 
labeled Mb, Me, Ma, and Ml0 in Fig. 3, have mean hydropathy 
indices over 17 residues ranging from 2.0 to 2.9. The remainder 
have mean hydropathy indices ranging from 0.8 to 1.6 and 
are less clear candidates for transmembrane sequences. In our 
earlier analysis of transmembrane segments of the Ca2+ ATP- 
ase (MacLennan et al., 1985), we predicted that 10 transmem- 
brane sequences with mean hydropathy indices ranging from 
1.3 to 2.7 would exist in this protein, and these included 
sequences which were relatively rich in polar and charged 
amino acids. We have obtained evidence recently (Clarke et 
al., 1989) that it is, indeed, these charged polar residues that 
are involved in forming the Ca’+-binding sites and the Ca2+ 
channel in the transmembrane domain of the Ca*+ ATPase. 
By analogy, we believe that it is unlikely that the Ca2+ release 
channel of the ryanodine receptor would be made up only of 
very hydrophobic sequences. Lodish (1988) has presented a 
similar view of the structure of membrane transport proteins. 
The COOH-terminal fifth of the ryanodine receptor mole- 
cule contains highly charged sequences in addition to the 
major hydrophobic stretches. In the folding model that would 
result from the assignment of sequences M’, M”, and Ml to 
Ml0 (Fig. 3) to the transmembrane sector, rather highly 
charged sequences would lie in the lumen of the terminal 
cisternae. The sequences RRRVRRLRR (residues 4307-4314) 
and EEAEGDEDE (residues 4612-4620) represent especially 
concentrated regions of positive and negative charges. A high 
density of charge surrounding the luminal mouth of the Ca*+ 
release channel might influence the gating properties of the 
channel or act as an ion selective screen at the channel 
entrance. It might also influence the interaction of luminal 
proteins such as calsequestrin (MacLennan and Wong, 1970) 
or calsequestrin-binding proteins (Mitchell et al., 1988) with 
the ryanodine receptor. 
Sequences labeled Ma, Mq and Ms are rich in glycine and 
alanine residues and Ms has a low hydropathy index, largely 
due to a cluster of glycine residues in the sequence. Glycine 
and alanine residues are compatible with transmembrane 
sequences, however, and one of the transmembrane sequences 
in subunit C of the bacterial FIFo ATPase complex (Walker 
et al., 1984; Senior, 1988) and transmembrane sequence D in 
the P-glycoprotein (Gras et al., 1987) are glycine and alanine 
rich. 
In a search for homology of the ryanodine receptor sequence 
with that of other known proteins, we noted amino acid 
identities between our proposed transmembrane segments Ms 
and Ma and segments Mz and Ms of the nicotinic acetylcholine 
receptor which, according to the model of Noda et al. (1983) 
has only four hydrophobic transmembrane segments. These 
identities are confined to two hydrophobic regions in the two 
molecules. While the regions of identity are contiguous in the 
acetylcholine receptor, they are separated by 160 residues 
encompassing putative transmembrane sequence M7 in the 
ryanodine receptor sequence. Another match in the region 
containing putative transmembrane sequences Ms-Mio can 
be made to the S4, S5 region of the Na+ channel (Noda et al., 
1984) and to the corresponding segment of the dihydropyri- 
dine-sensitive Ca*+ channel (Tanabe et al., 1987). One of these 
matches is shown in Fig. 3. Since the matches are mainly 
hydrophobic in a region rich in such residues, they are unlikely 
to be significant. The lack of significant homology of the 
ryanodine receptor with other channel proteins suggests that 
the ryanodine receptor may be the first member of a novel 
family of channel proteins that might contain other intracel- 
lular Ca2+ release channels such as the cardiac form of the 
ryanodine receptor (Lai et al., 1988b; Inui et al., 1987b) or the 
inositol trisphosphate receptor (Supattapone et al., 1988), 
which have been identified, but not yet cloned. 
Our attempts to identify nucleotide-binding sites in the 
primary sequence were not successful. Known nucleotide- 
binding sites are almost invariably in parallel /3 sheet domains 
and perhaps half of them include a glycine-rich bend in the 
first (~$3 unit of the sheet. The glycine-rich sequence 
GLGDMG, (residues 4447-4452) noted earlier (Takeshima et 
al., 1989), is present in a glycine-proline-rich region which 
would not be predicted to form a typical nucleotide-binding 
domain. Our present information on the structural features 
of the nucleotide-binding site derives largely from proteins 
such as muscle adenylate kinase (Fry et al., 1986) which has 
a high affinity for ATP of the order of 30 FM (Noda, 1973). 
Half-maximal activation of the Ca*+ release channel, either 
in planar bilayers (Smith et al., 1986; Smith et al., 1988) or in 
intact heavy sarcoplasmic reticulum vesicles (Morii and Ton- 
omura, 1983; Meissner et al., 1986) occurs at about 2 mM 
ATP, indicating that the activation of Ca*+ release by ATP is 
due to the interaction of the ligand with low affinity binding 
sites which may not be closely related to those with high 
affinity. 
The search for high affinity Ca*+-binding sites of the EF 
hand type was also unsuccessful. Since high affinity Ca2+ 
binding occurs in many proteins of known structure which do 
not contain EF hand structures, this is not surprising. For 
example, in a recent study, Fliegel et al. (1989) have defined 
the primary sequence of the high affinity Ca*+-binding protein 
(calreticulin) of the sarcoplasmic reticulum (Ostwald and 
MacLennan, 1974). Although this protein of 400 amino acids 
binds 1 mol of Ca*+/mol with high affinity and 25 mol of 
Ca’+/mol with low affinity, no clear EF hand sequences were 
present in the molecule. In analogy with the long acidic 
sequence in the ryanodine receptor (residues 1872-1923, Fig. 
l), 32 out of 40 amino acids near the COOH terminus of 
calreticulin were acidic. Thus, in both calreticulin and the 
ryanodine receptor, high affinity Ca2+ binding occurs in the 
absence of a clear EF hand sequence, but in the presence of a 
long acidic sequence. The determination of the Ca*+ binding 
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properties of both of these long acidic sequences will be of 
great interest. 
Our search for calmodulin-binding sites revealed a number 
of candidate sequences lying near the center of the molecule. 
If these sites are functional, they would indicate that modu- 
lation of the channel could occur in domains that are distant 
in the primary sequence from the sequences most likely to 
make up the release channel itself. Potential phosphorylation 
sites were found in the sequence just upstream from the 
probable channel forming sequences in regions that we predict 
to be cytoplasmic. Although phosphorylation of the channel 
has been reported (Seiler et al., 1984), regulation of the 
channel by phosphorylation has not been reported. 
Several consensus glycosylation sites were found in the 
sequence but all were in regions that we predict to be cyto- 
plasmic. Since glycosylation reactions occurred in the lumen 
of the endoplasmic reticulum (Lennarz, 1987), which has the 
same orientation as the sarcoplasmic reticulum, none of these 
would be predicted to be glycosylated. An alternative folding 
pattern (Takeshima et al., 1989) could lead to the luminal 
location and glycosylation of residue 4859, however. To date, 
no detailed study of glycosylation of the ryanodine receptor 
has been published. 
The primary sequence of the ryanodine receptor provides 
us with the first important clues to the understanding of the 
structure/function relationships in the molecule. Further in- 
formation is likely to arise from detailed investigation of the 
biochemical properties of altered forms of the molecule such 
as those which can be obtained through site-specific or natu- 
rally occurring mutations. 
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